Literature DB >> 17556597

Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow.

Ming-Song Tsai1, Shiaw-Min Hwang, Kuang-Den Chen, Yun-Shien Lee, Li-Wen Hsu, Yu-Jen Chang, Chao-Nin Wang, Hsiu-Huei Peng, Yao-Lung Chang, An-Shine Chao, Shuenn-Dyh Chang, Kuan-Der Lee, Tzu-Hao Wang, Hsin-Shih Wang, Yung-Kuei Soong.   

Abstract

Using high-density oligonucleotide microarrays and functional network analyses, we examined whether MSCs derived from four different origins exhibited unique gene expression profiles individually and then compared the gene expression profiles of all MSCs with those of fetal organs. Our results indicated that within each group of MSCs from the same origin, the variability of the gene expression levels was smaller than that between groups of different origins. Functional genomic studies revealed the specific roles of MSCs from different origins. Our results suggest that amniotic fluid MSCs may initiate interactions with the uterus by upregulating oxytocin and thrombin receptors. Amniotic membrane MSCs may play a role in maintaining homeostasis of fluid and electrolytes by regulating the networks of endothelin, neprilysin, bradykinin receptors, and atrial natriuretic peptide. Cord blood MSCs may be involved in innate immune systems as the neonatal defense system against the earliest encountered pathogens. Adult bone marrow MSCs may be an important source not only of all blood lineages but also of bone formation. However, in spite of the different gene expression profiles seen in MSCs derived from different origins, a set of core gene expression profiles was preserved in these four kinds of MSCs. The core signature transcriptomes of all MSCs, when contrasted against those of fetal organs, included genes involved in the regulation of extracellular matrix and adhesion, transforming growth factor-beta receptor signaling, and the Wnt signaling pathways. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556597     DOI: 10.1634/stemcells.2007-0023

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  58 in total

Review 1.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

2.  Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential.

Authors:  L-Y Sun; D-K Hsieh; W-S Syu; Y-S Li; H-T Chiu; T-W Chiou
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

3.  Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.

Authors:  Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-26

4.  SOX9 as a Predictor for Neurogenesis Potentiality of Amniotic Fluid Stem Cells.

Authors:  Pei-Cih Wei; Angel Chao; Hsiu-Huei Peng; An-Shine Chao; Yao-Lung Chang; Shuenn-Dyh Chang; Hsin-Shih Wang; Yu-Jen Chang; Ming-Song Tsai; Martin Sieber; Hua-Chien Chen; Shu-Jen Chen; Yun-Shien Lee; Shiaw-Min Hwang; Tzu-Hao Wang
Journal:  Stem Cells Transl Med       Date:  2014-08-25       Impact factor: 6.940

Review 5.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

Review 6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 7.  MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.

Authors:  Konstantinos Sdrimas; Stella Kourembanas
Journal:  Antioxid Redox Signal       Date:  2014-02-24       Impact factor: 8.401

8.  Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.

Authors:  Offer Erez; Roberto Romer; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Ricardo Gomez; Eli Maymon; Percy Pacora; Samuel S Edwin; Chong Jai Kim; Nandor Gabor Than; Pooja Mittal; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

9.  Isolation, characterization, and differentiation of stem cells for cartilage regeneration.

Authors:  Olivia S Beane; Eric M Darling
Journal:  Ann Biomed Eng       Date:  2012-08-21       Impact factor: 3.934

Review 10.  Stem cells in amniotic fluid as new tools to study human genetic diseases.

Authors:  Nicol Siegel; Margit Rosner; Michaela Hanneder; Alessandro Valli; Markus Hengstschläger
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.